Sequence UPI00000CF9B7
Found in 7 databases: Protein Research Foundation (PRF), RefSeq, Japan Patent Office (JPO), EMBL CDS, European Patent Office (EPO), US Patent Office (USPO) and UniProtKB
| Database | Entry | Version | Organism | First seen | Last seen | Active |
|---|---|---|---|---|---|---|
| EMBL CDS | BAB80399 | 1 | Clostridium perfringens str. 13 | 2003-03-12 | 2009-09-04 | Yes |
| EMBL CDS | BAG69287 | 1 | Clostridium perfringens | 2008-08-27 | 2009-09-04 | Yes |
| EMBL CDS | CAM83938 | 1 | Clostridium perfringens str. 13 | 2007-04-02 | 2009-09-04 | Yes |
| UniProtKB/TrEMBL | Q8XMJ5 | 1 | Clostridium perfringens | 2002-03-01 | 2009-11-24 | Yes |
| European Patent Office (EPO) | CS499393 | 1 | 2007-06-09 | 2009-09-10 | Yes | |
| US Patent Office (USPO) | ACK18392 | 1 | 2009-01-05 | 2009-10-22 | Yes | |
| Japan Patent Office (JPO) | BD941539 | 2008-03-13 | 2009-10-23 | Yes | ||
| RefSeq | NP_561609 | 1 | Clostridium perfringens str. 13 | 2004-07-08 | 2009-09-07 | Yes |
| Protein Research Foundation (PRF) | 2805303AJL | Clostridium perfringens | 2005-11-28 | 2009-09-01 | Yes |
| Sequence | Length | Mass (Da) | |
|---|---|---|---|
|
UPI00000CF9B7
Checksum: 00F276EBE357453B | 1,686 | 187,826 | |
10 20 30 40 50 60
MGRKCMNKKI AAIIAAAVIV GQLPISVLAT PVNEAGDEIN SESAEILTNS DEEAEAYIQN
70 80 90 100 110 120
YDRPEGITWT KLAGSGSVEV TDGFLSVTNN GDYRIMEDQS PNIKNGELES KFTVGGSQTG
130 140 150 160 170 180
IIFRATESNY GMINYNSGTG WVIENKNSWE DITGPKLNNG DVVTVKATFV EKHLTVNVSV
190 200 210 220 230 240
NDGEFETIYD KESDLIPLQA GKVGYRGWGN AKTTKFDYIK YAPMTIDKGP IVSINEVNVE
250 260 270 280 290 300
TYPRVKPILP SSVTVNHENG MSSIKDVSWN YIPKESYSKP GTFKVEGTVE GTDVKAIANV
310 320 330 340 350 360
TVSSDLAYYE TNFETEETRG DWQVVQGGGS PSYEEGKVKI PMNGVSIAVD MNSPEVKNFT
370 380 390 400 410 420
YETDFSVDNN GGRIGLLFRY VSETEWGAVC YDNGSWVWKT GDGKYGNFPG TFTPEPGKTY
430 440 450 460 470 480
RIKLKVEDTN ITMWVDGEKI GQVAVSNLPD VRGKVGLTGW FGNKNVTLDN LVVEELGGIM
490 500 510 520 530 540
APEVGPLEEQ SIESDSMKVV LDNRFPTVIR YEWKGTEDVL SGASVDDLEA QYMVEINGEK
550 560 570 580 590 600
RIPKVTSEFA NNEGIYTLNF EDIGMTITLK MTVNENKLRM EVTDIQEGDV KLQTLNFPNH
610 620 630 640 650 660
SLASVSSLNN GKTASVLTTG DWNNINEEFT DVAKAKPGVK GKTYAFINDD KFAVTINNNT
670 680 690 700 710 720
IEGGNRVVLT TENDTLPDNT NYKKVGISNG TWTYKEILQD TTDQGSKLYQ GEKPWSEVII
730 740 750 760 770 780
ARDENEDGQV DWQDGAIQYR KNMKIPVGGE EIKNQMSYID FNIGYTQNPF LRSLDTIKKL
790 800 810 820 830 840
SNYTDGFGQL VLHKGYQGEG HDDSHPDYGG HIGMRQGGKE DFNTLIEQGK EYNAKIGVHI
850 860 870 880 890 900
NATEYTMDAF EYPTELVNEN APGWGWLDQA YYVNQRGDIT SGELFRRLDM LMEDAPELGW
910 920 930 940 950 960
IYVDVYTGNG WNAHQLGEKI NDYGIMIATE MNGPLEQHVP WTHWGGDPAY PNKGNASKIM
970 980 990 1000 1010 1020
RFMKNDTQDS FLADPLVKGN KHLLSGGWGT RHDIEGAYGT EVFYNQVLPT KYLQHFQITK
1030 1040 1050 1060 1070 1080
MSENEVLFEN GVKAVRENSN INYYRNDRLV ATTPENSIGN TGIGDTQLFL PWNPVDEANS
1090 1100 1110 1120 1130 1140
EKIYHWNPLG TTSEWTLPEG WTSNDKVYLY ELSDLGRTLV KEVPVVDGKV NLEVKQDTPY
1150 1160 1170 1180 1190 1200
IVTKEKVEEK RIEDWGYGSE IADPGFDSQT FDKWNKESTA ENTDHITIEN ESVQKRLGND
1210 1220 1230 1240 1250 1260
VLKISGNEGA DAKISQSISG LEEGVTYSVS AWVKNDNNRE VTLGVNVGGK DFTNVITSGG
1270 1280 1290 1300 1310 1320
KVRQGEGVKY IDDTFVRMEV EFTVPKGVNS ADVYLKASEG DADSVVLVDD FRIWDHPGHT
1330 1340 1350 1360 1370 1380
NRDGYVFYED FENVDEGISP FYLSPGRGHS NRSHLAEKDI SIDANQRMNW VLDGRFSLKS
1390 1400 1410 1420 1430 1440
NQQPKEIGEM LTTDVSSFKL EPNKTYEFGF LYSLENAAPG YSVNIKNRDG EKIVSIPLEA
1450 1460 1470 1480 1490 1500
TGSNYAQDIF TKTKSVTHEF TTGDFAGDYY ITLEKGDGFK EVILDNIYVK EIDKSIESPE
1510 1520 1530 1540 1550 1560
LAHVNLNTVE HDLEVGQSVP FAINALMNNG ANVNLEEAEV EYKVSKPEVL TIENGMMTGA
1570 1580 1590 1600 1610 1620
SEGFTDVQVN ITVNGNKVSS NTVRVKVGNP EVEEEEVIVN PVRNFKVTDK TKKNVTVSWE
1630 1640 1650 1660 1670 1680
EPEKTYGLEG YVLYKDGKKV KEIGADKTEF TFKGLNRHTI YNFKIAAKYS NGELSTKESI
TVRTAR |
